Time Will Tell If FDA Review Update Quickens Drug Approval
The latest U.S. Food and Drug Administration user fee update aims to reduce new-drug review times by, perhaps counterintuitively, giving the FDA more time for review, but regulatory attorneys say it...To view the full article, register now.
Already a subscriber? Click here to view full article